During the past decade, Marietta Dermatology Clinical Research, Inc. conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 7 clinical trials were completed, i.e. on average, 53.8% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 6 clinical trials were completed. i.e. 120% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Marietta Dermatology Clinical Research, Inc." #1 sponsor was "Eli Lilly and Company" with 4 trials, followed by "Dermira, Inc." with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "Elorac, Inc." with 1 trials sponsored and "LEO Pharma" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Marietta Dermatology Clinical Research, Inc." #1 collaborator was "Dermira, Inc." with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Marietta Dermatology Clinical Research, Inc." are "Atopic Dermatitis" (5 trials), "Acne Vulgaris" (2 trials), "Psoriasis" (2 trials), "Cutaneous Common Warts" (1 trials) and "Hidradenitis Suppurativa" (1 trials). Many other conditions were trialed in "Marietta Dermatology Clinical Research, Inc." in a lesser frequency.

Most popular intervention types in "Marietta Dermatology Clinical Research, Inc." are "Drug" (11 trials), "Biological" (3 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Lebrikizumab" (3 trials), "Guselkumab" (2 trials), "Olumacostat Glasaretil Gel, 5.0%" (2 trials) and "CLS006" (1 trials). Other intervention names were less common.

The vast majority of trials in "Marietta Dermatology Clinical Research, Inc." are 12 trials for "All" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Marietta Dermatology Clinical Research, Inc.". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Marietta Dermatology Clinical Research, Inc., undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Marietta Dermatology Clinical Research, Inc., 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".